Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503605 | SCV000597403 | likely benign | not specified | 2016-07-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000503605 | SCV003749975 | uncertain significance | not specified | 2021-10-27 | criteria provided, single submitter | clinical testing | The c.713A>C (p.K238T) alteration is located in exon 2 (coding exon 2) of the TBC1D4 gene. This alteration results from a A to C substitution at nucleotide position 713, causing the lysine (K) at amino acid position 238 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004705632 | SCV005215685 | likely benign | not provided | criteria provided, single submitter | not provided |